Literature DB >> 15838313

Endothelin-1 induces cyclooxygenase-2 expression and generation of reactive oxygen species in endothelial cells.

Toru Sugiyama1, Takanobu Yoshimoto, Ryuji Sato, Nozomi Fukai, Naoko Ozawa, Masayoshi Shichiri, Yukio Hirata.   

Abstract

Since both endothelin-1 (ET-1) and aldosterone have been shown to induce expression of several pro-inflammatory genes, including cyclooxygenase-2 (COX-2), in the vasculature as a cardiovascular risk hormone, the present study was undertaken to examine the effects of ET-1 and aldosterone on COX-2 gene expression as measured by a real-time reverse transcriptase-polymerase chain reaction in aortic endothelial cells. Treatment with ET-1(10 M) markedly upregulated COX-2 mRNA levels in rat endothelial cells, whereas aldosterone (10 M) did not show any effect. The ET-1-induced COX-2 upregulation was inhibited by pretreatment with a non-selective endothelin receptor antagonist (TAK044), a protein kinase C inhibitor (GF109203X), and a MEK inhibitor (PD98059). Furthermore, ET-1 increased intracellular reactive oxygen species generation as estimated by the measurement of dichlorofluorescein fluorescence, whose effect was blocked by a COX-2 inhibitor (NS398). Our data show that ET-1 induces COX-2 upregulation in rat endothelial cells via a protein kinase C-dependent and extracellular signal-regulated kinase-dependent pathway, which may largely contribute to the generation of intracellular reactive oxygen species.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15838313     DOI: 10.1097/01.fjc.0000166267.17174.0e

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  7 in total

1.  Reversal of cardiac dysfunction by selective ET-A receptor antagonism.

Authors:  Anthony Allan; Andrew Fenning; Scott Levick; Andrew Hoey; Lindsay Brown
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

2.  The cardiovascular effect of the uremic solute indole-3 acetic acid.

Authors:  Laetitia Dou; Marion Sallée; Claire Cerini; Stéphane Poitevin; Bertrand Gondouin; Noemie Jourde-Chiche; Karim Fallague; Philippe Brunet; Raymond Calaf; Bertrand Dussol; Bernard Mallet; Françoise Dignat-George; Stephane Burtey
Journal:  J Am Soc Nephrol       Date:  2014-08-21       Impact factor: 10.121

3.  Modulation of inflammatory response by selective inhibition of cyclooxygenase-1 and cyclooxygenase-2 in acute kidney injury.

Authors:  Carla Q Feitoza; Patricia Semedo; Giselle M Gonçalves; Marcos A Cenedeze; Hélady S Pinheiro; Oscar Fernando Pavão Dos Santos; Richardt Gama Landgraf; Alvaro Pacheco-Silva; Niels Olsen Saraiva Câmara
Journal:  Inflamm Res       Date:  2009-08-27       Impact factor: 4.575

4.  Effect of endothelin-1 on cyclooxygenase-2 expression in human hormone refractory prostate cancer cells.

Authors:  Qi Su; Rui-Peng Jia; Jianzhong Lin; Lu-Wei Xu; Zi-Zheng Wang; Wen-Cheng Li; Shu-Kui Wang
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

5.  The Effect of Angiotensin on the Quality of In Vitro Produced (IVP) Sheep Embryos and Expression of Na(+)/K(+)/ATPase.

Authors:  Mohammad Mehdi Naderi; Sara Borjian Boroujeni; Ali Sarvari; Banafsheh Heidari; Mohammad Mehdi Akhondi; Amir-Hassan Zarnani; Abolfazl Shirazi
Journal:  Avicenna J Med Biotechnol       Date:  2016 Jan-Mar

Review 6.  Aspirin for the prevention and treatment of pre-eclampsia: A matter of COX-1 and/or COX-2 inhibition?

Authors:  Katrina M Mirabito Colafella; Rugina I Neuman; Willy Visser; A H Jan Danser; Jorie Versmissen
Journal:  Basic Clin Pharmacol Toxicol       Date:  2019-09-11       Impact factor: 4.080

7.  Effects of insulin resistance and testosterone on the participation of cyclooxygenase isoforms in vascular reactivity.

Authors:  Harish Vasudevan; Sally Lau; Jihong Jiang; John H McNeill
Journal:  J Exp Pharmacol       Date:  2010-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.